Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Usana Health Sciences (USNA) over the last 16 years, with Q3 2025 value amounting to $41000.0.

  • Usana Health Sciences' Other Non Operating Income rose 14767.44% to $41000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 31698.69%. This contributed to the annual value of -$1.0 million for FY2024, which is 1454285.71% down from last year.
  • Latest data reveals that Usana Health Sciences reported Other Non Operating Income of $41000.0 as of Q3 2025, which was up 14767.44% from $1.7 million recorded in Q2 2025.
  • Usana Health Sciences' 5-year Other Non Operating Income high stood at $1.7 million for Q2 2025, and its period low was -$1.2 million during Q1 2022.
  • Over the past 5 years, Usana Health Sciences' median Other Non Operating Income value was -$292000.0 (recorded in 2022), while the average stood at -$202315.8.
  • In the last 5 years, Usana Health Sciences' Other Non Operating Income plummeted by 76986.3% in 2022 and then soared by 59828.08% in 2025.
  • Quarter analysis of 5 years shows Usana Health Sciences' Other Non Operating Income stood at -$889000.0 in 2021, then plummeted by 32.28% to -$1.2 million in 2022, then soared by 68.71% to -$368000.0 in 2023, then decreased by 5.98% to -$390000.0 in 2024, then soared by 110.51% to $41000.0 in 2025.
  • Its last three reported values are $41000.0 in Q3 2025, $1.7 million for Q2 2025, and $756000.0 during Q1 2025.